Investment Reporting & Treasury Associate

Overview

• Maintain consolidated investment reporting across all asset classes and entities including private investments (VC, PE, co-investments), public markets, and structured products.
• Track and update performance metrics such as IRR, MOIC, DPI, and TVPI.
• Maintain internal dashboards and reporting packs for the principal.
• Flag discrepancies, stale data, and missing updates proactively.
• Maintain accurate and current reference valuations for private investments, including tracking latest funding rounds, market reference points, and secondary market activity.
• Apply understanding of discounts to NAV, liquidity-driven vs fundamental pricing, and market sentiment vs reported valuations.
• Cross-check fund-reported NAV against observable secondary transactions and flag misalignment.
• Act as primary point of contact for all external counterparties including private banks, asset managers, and GPs ensuring timely receipt of all reporting.
• Maintain a counterparty-level reporting tracker and follow up proactively on delays or missing data.
• Maintain real-time visibility over liquidity across all entities including capital calls, funding timelines, scheduled payments, and liquidity requirements.
• Coordinate with Finance Operations for execution readiness.
• Own all India-related reporting, coordination, and tracking including interfacing with Indian CAs, legal advisors, and service providers.
• Maintain centralized tracker of filings, deadlines, and documentation requirements ensuring completeness and timeliness.
• Track capital flow including investments, distributions, exits, and repatriation timelines, coordinating cross-border flows.
• Maintain structured records across investments, capital flows, and filings including reconciliation of discrepancies.
• Ensure all reporting is accurate, complete, and delivered on time maintaining structured calendars for reporting cycles and deadlines.
• Identify gaps proactively and escalate early with context.
• Own deliverables end-to-end and avoid reactive follow-ups.